A judge in Washington on Wednesday barred US technology company Apple from selling two flagship smartwatch models in the United States over a patent dispute between Apple and Masimo. It was written by Reuters on Thursday, according to which the legal battle could last up to a year. Apple therefore decided to disable the controversial feature to comply with the ban and keep the watch on sale.
Washington
7:44 AM January 18, 2024 Share on Facebook
Share on LinkedIn
Copy the url address
Abbreviated address Copy to clipboard
Apple Smart Watch, Illustration Photo | Photo: Kabir Jhangiani | Source: Reuters
Masimo, which specializes in health technology, accuses Apple of luring its employees, stealing its technology for measuring blood oxygen levels and incorporating it into its watches.
Apple failed to convince a US federal appeals court to allow imports of Apple Watches with technology for reading blood-oxygen levels while it challenges a government tribunal’s decision that the devices infringe patents belonging to medical company Masimo pic.twitter.com/OZSV5Tu6oG
— Reuters (@Reuters) January 17, 2024
Because of the dispute, at the end of last year, Apple had to briefly suspend the sale of the Series 9 and Ultra 2 watches, but later the American court allowed it again. Now the sales ban was supposed to apply again, but Apple will avoid it by selling the watch from Thursday morning without the app allowing blood oxygen level measurement to be available.
Although Apple does not disclose how many smartwatches it sells annually, according to the AP agency, analysts estimate that this product will bring the company around $18 billion (410 billion CZK) in annual revenue.
Share on Facebook
Share on LinkedIn
Copy the url address
Abbreviated address Copy to clipboard
2024-01-18 06:44:00
#Apple #sell #smartwatch #models #court #rules #reason #patent #dispute
